Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

27 avril 2026 mis à jour par: Alliance for Clinical Trials in Oncology

A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer

This randomized phase III trial studies how well education with or without physical therapy intervention works in preventing lymphedema in women with stage I, II, or III breast cancer who are undergoing axillary lymph node dissection (surgery to remove lymph nodes found in the armpit region). Lymphedema is a condition in which extra lymph fluid builds up in tissues and causes swelling in an arm or leg if lymph vessels are blocked, damaged, or removed by surgery. A personalized physical therapy intervention and education materials may be better than education materials alone in preventing lymphedema in women with breast cancer who are undergoing axillary lymph node dissection.

Aperçu de l'étude

Description détaillée

OBJECTIVES:

I. To test, in a group randomized controlled trial, the efficacy of this program versus education only in reducing the incidence of lymphedema.

II. To compare the severity of lymphedema, in terms of changes in arm circumference at the site of greatest difference as a continuous variable between the two interventions.

III. To assess the agreement between patients' self-report of swelling (mild, moderate, and severe) and the extent of circumferential measurement difference between the treated side and the contralateral arm at the site of greatest difference.

IV. To compare the health-related quality of life (Factional Assessment of Cancer Therapy-Breast [FACT-B]+4 score) between the two interventions.

V. To characterize adherence to lymphedema prevention exercises, lymphedema knowledge, and range of motion.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Six weeks after surgery, patients receive a brief initial post-operative care session describing lymphedema risk and prevention through oral instruction and written materials. Patients complete physical assessments and questionnaires at 6 weeks and at 6, 12, and 18 months. Patients are also contacted by telephone at 9 and 15 months.

ARM II: Patients receive lymphedema education and complete physical assessments and questionnaires as in Arm I. Patients also complete a personalized physical therapy intervention, receive a refrigerator magnet, and a 15-minute video that reinforces information and exercises.

Type d'étude

Interventionnel

Phase

  • Phase 3

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • California
      • Castro Valley, California, États-Unis, 94546
        • East Bay Radiation Oncology Center
      • Castro Valley, California, États-Unis, 94546
        • Valley Medical Oncology Consultants - Castro Valley
      • Concord, California, États-Unis, 94524-4110
        • Cancer Care Center at John Muir Health - Concord Campus
      • Fremont, California, États-Unis, 94538
        • Valley Medical Oncology
      • Martinez, California, États-Unis, 94553-3156
        • Contra Costa Regional Medical Center
      • Mountain View, California, États-Unis, 94040
        • El Camino Hospital Cancer Center
      • Oakland, California, États-Unis, 94609
        • Alta Bates Summit Medical Center - Summit Campus
      • Oakland, California, États-Unis, 94602
        • Highland General Hospital
      • Oakland, California, États-Unis, 94609
        • Larry G Strieff MD Medical Corporation
      • Oakland, California, États-Unis, 94609
        • CCOP - Bay Area Tumor Institute
      • Oakland, California, États-Unis, 94609
        • Bay Area Breast Surgeons, Incorporated
      • Oakland, California, États-Unis, 94609
        • Tom K Lee, Incorporated
      • San Pablo, California, États-Unis, 94806
        • Doctors Medical Center - San Pablo Campus
      • Walnut Creek, California, États-Unis, 94598
        • John Muir/Mt. Diablo Comprehensive Cancer Center
    • Connecticut
      • Bridgeport, Connecticut, États-Unis, 06606
        • St. Vincent's Medical Center
    • Delaware
      • Lewes, Delaware, États-Unis, 19958
        • Tunnell Cancer Center at Beebe Medical Center
      • Newark, Delaware, États-Unis, 19713
        • CCOP - Christiana Care Health Services
    • District of Columbia
      • Washington D.C., District of Columbia, États-Unis, 20007
        • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
      • Washington D.C., District of Columbia, États-Unis, 20002
        • Kaiser Permanente at Capitol Hill Medical Center
    • Florida
      • Dearfield Beach, Florida, États-Unis, 33064-3596
        • North Broward Medical Center
      • Jupiter, Florida, États-Unis, 33458
        • Ella Milbank Foshay Cancer Center at Jupiter Medical Center
      • Miami Beach, Florida, États-Unis, 33140
        • CCOP - Mount Sinai Medical Center
      • Pensacola, Florida, États-Unis, 32504
        • Sacred Heart Cancer Center at Sacred Heart Hospital
      • Tallahassee, Florida, États-Unis, 32308
        • Tallahassee Memorial Hospital
    • Illinois
      • Chicago, Illinois, États-Unis, 60637-1470
        • University of Chicago Cancer Research Center
      • Chicago, Illinois, États-Unis, 60631
        • Resurrection Medical Center
      • Elk Grove Village, Illinois, États-Unis, 60007
        • Alexian Brothers Radiation Oncology
      • Harvey, Illinois, États-Unis, 60426
        • Ingalls Cancer Care Center at Ingalls Memorial Hospital
      • Moline, Illinois, États-Unis, 61265
      • Moline, Illinois, États-Unis, 61265
        • Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    • Indiana
      • La Porte, Indiana, États-Unis, 46350
        • Center for Cancer Therapy at LaPorte Hospital and Health Services
      • Mishawaka, Indiana, États-Unis, 46545-1470
        • Saint Joseph Regional Medical Center
      • South Bend, Indiana, États-Unis, 46601
        • Memorial Hospital of South Bend
      • South Bend, Indiana, États-Unis, 46601
        • CCOP - Northern Indiana CR Consortium
      • South Bend, Indiana, États-Unis, 46601
        • Michiana Hematology-Oncology, PC - South Bend
    • Iowa
      • Bettendorf, Iowa, États-Unis, 52722
    • Kansas
      • Chanute, Kansas, États-Unis, 66720
        • Cancer Center of Kansas, PA - Chanute
      • Dodge City, Kansas, États-Unis, 67801
        • Cancer Center of Kansas, PA - Dodge City
      • El Dorado, Kansas, États-Unis, 67042
        • Cancer Center of Kansas, PA - El Dorado
      • Fort Scott, Kansas, États-Unis, 66701
        • Cancer Center of Kansas - Fort Scott
      • Independence, Kansas, États-Unis, 67301
        • Cancer Center of Kansas-Independence
      • Kingman, Kansas, États-Unis, 67068
        • Cancer Center of Kansas, PA - Kingman
      • Lawrence, Kansas, États-Unis, 66044
        • Lawrence Memorial Hospital
      • Liberal, Kansas, États-Unis, 67901
        • Cancer Center of Kansas, PA - Liberal
      • McPherson, Kansas, États-Unis, 67460
        • Cancer Center of Kansas, PA - McPherson
      • Newton, Kansas, États-Unis, 67114
        • Cancer Center of Kansas, PA - Newton
      • Parsons, Kansas, États-Unis, 67357
        • Cancer Center of Kansas, PA - Parsons
      • Pratt, Kansas, États-Unis, 67124
        • Cancer Center of Kansas, PA - Pratt
      • Salina, Kansas, États-Unis, 67401
        • Cancer Center of Kansas, PA - Salina
      • Wellington, Kansas, États-Unis, 67152
        • Cancer Center of Kansas, PA - Wellington
      • Wichita, Kansas, États-Unis, 67208
        • Cancer Center of Kansas, PA - Medical Arts Tower
      • Wichita, Kansas, États-Unis, 67214
        • Cancer Center of Kansas, PA - Wichita
      • Wichita, Kansas, États-Unis, 67214
        • CCOP - Wichita
      • Wichita, Kansas, États-Unis, 67214
        • Via Christi Cancer Center at Via Christi Regional Medical Center
      • Wichita, Kansas, États-Unis, 67208
        • Associates in Womens Health, PA - North Review
      • Winfield, Kansas, États-Unis, 67156
        • Cancer Center of Kansas, PA - Winfield
    • Kentucky
      • Lexington, Kentucky, États-Unis, 40503-9985
        • Central Baptist Hospital
    • Maine
      • York Village, Maine, États-Unis, 03909
        • York Hospital's Oncology Treatment Center
    • Maryland
      • Baltimore, Maryland, États-Unis, 21244
        • Kaiser Permanente at Woodlawn Medical Center
      • Elkton MD, Maryland, États-Unis, 21921
        • Union Hospital of Cecil County
      • Gaithersburg, Maryland, États-Unis, 20879
        • Kaiser Permanente - Gaithersburg Medical Center
      • Largo, Maryland, États-Unis, 20774
        • Kaiser Permanente Mid-Atlantic Medical Group-Largo Medical Facility
      • Silver Spring, Maryland, États-Unis, 20910
        • Holy Cross Hospital
    • Massachusetts
      • Boston, Massachusetts, États-Unis, 02111
        • Tufts Medical Center Cancer Center
      • Hyannis, Massachusetts, États-Unis, 02601
        • Cape Cod Hospital
    • New Jersey
      • Elizabeth, New Jersey, États-Unis, 07207
        • Trinitas Comprehensive Cancer Center at Trinitas Hospital
      • Voorhees Township, New Jersey, États-Unis, 08043
        • Cancer Institute of New Jersey at Cooper - Voorhees
    • New York
      • Staten Island, New York, États-Unis, 10305
        • Nalitt Cancer Institute at Staten Island University Hospital
    • North Carolina
      • Greenville, North Carolina, États-Unis, 27834
        • Leo W. Jenkins Cancer Center at ECU Medical School
    • North Dakota
      • Fargo, North Dakota, États-Unis, 58122
        • CCOP - MeritCare Hospital
    • Ohio
      • Columbus, Ohio, États-Unis, 43210-1240
        • Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    • Tennessee
      • Cookeville, Tennessee, États-Unis, 38501
        • Cookeville Regional Medical Center
    • Texas
      • Houston, Texas, États-Unis, 77030-4009
        • M. D. Anderson Cancer Center at University of Texas
      • Laredo, Texas, États-Unis, 78045
        • Doctor's Hospital of Laredo
    • Virginia
      • Fairfax, Virginia, États-Unis, 22033
        • Kaiser Permanente Medical Center - Fair Oaks
      • McLean, Virginia, États-Unis, 22102
        • Kaiser Permanente Tysons Corner Medical Center

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

La description

Eligibility Criteria:

  • Newly diagnosed with stage I-III cancer of the female breast
  • No prior history of carcinoma in situ, lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), or invasive breast cancer

    * Patients with a history of other invasive malignancies are eligible as long as they have completed treatment and are 5 years post-diagnosis; patients with basal cell and squamous cell cancer of the skin are eligible

  • Neoadjuvant therapy

    • Patients scheduled to receive any type of radiation therapy to the breast or axilla are eligible; however, they must be registered to this study with pre-surgery measures taken prior to receiving neoadjuvant therapy
    • Patients scheduled to receive neoadjuvant chemotherapy are also eligible; however, they must be registered to this study with pre-surgery measurements taken prior to receiving neoadjuvant therapy
    • Patients receiving no neoadjuvant therapy are eligible
  • May be enrolled on other treatment trials; however, patients enrolled on surgery trials where only one treatment arm is full axillary node dissection are not eligible; NOTE: Patients enrolled on American College of Surgeons Oncology Group (ACOSOG)-Z1071 are eligible to participate in this study; patients concurrently enrolled on this study and ACOSOG-Z1071, may not also be enrolled on the ACOSOG-Z1071 lymphedema sub-study
  • No documented cardiac conduction disturbances, unstable angina, dementia, or any other chronic disease which, in the opinion of the treating physician, significantly increases mortality over the next 2 years
  • No diagnosed lymphedema
  • In order to be properly fitted for the elastic sleeve, eligible patients must have arm measurements for axilla, elbow, and wrist that fall within the ranges for one of the six sleeve sizes
  • Not currently homebound or dependent upon a walker or wheelchair for mobility
  • Able to participate in a mild exercise program
  • Willing to return to the study site for the duration of the study (18 months)
  • Sentinel (SND) or full axillary node dissection (AND) (no minimum number of nodes required)
  • Patients with double mastectomy, axillary node dissection and/or radiation on both arms are ineligible; patients who undergo these treatments (i.e., surgery and/or radiation) on the contralateral arm after registration to Step 2 are still eligible to remain in the study; however, it should be documented appropriately on form C-1628 at the conclusion of study participation

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Arm I (lymphedema education)
Six weeks after surgery, patients receive a brief initial post-operative care session describing lymphedema risk and prevention through oral instruction and written materials. Patients complete physical assessments and questionnaires at 6 weeks and at 6, 12, and 18 months. Patients are also contacted by telephone at 9 and 15 months.
Ancillary studies
Receive lymphedema educational materials
Autres noms:
  • d'intervention, d'éducation
Expérimental: Arm II (lymphedema education, physical therapy)
Description Patients receive lymphedema education and complete physical assessments and questionnaires as in Arm I. Patients also complete a personalized physical therapy intervention, receive a refrigerator magnet, and a 15-minute video that reinforces information and exercises.
Ancillary studies
Receive lymphedema educational materials
Autres noms:
  • d'intervention, d'éducation
Complete physical therapy-focused intervention
Autres noms:
  • physiothérapie

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Number of Participants Who Were Lymphedema-free 18 Months After Randomization
Délai: 18 months
To test, in a group randomized controlled trial, the efficacy of this program versus education only in reducing the incidence of lymphedema. Reported here is the proportion of patients who are lymphedema-free 18 months after randomization between the two arms
18 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change From Baseline at 18 Months in Arm Circumference at the Site of Greatest Difference
Délai: 18 months
To compare the severity of lymphedema in terms of changes in arm circumference at the site of greatest difference as a continuous variable between the two interventions.
18 months
Agreement Between Patients' Self-report of Swelling and the Extent of Circumferential Measurement Difference Between the Treated Side and the Contralateral Arm
Délai: 18 months
To assess the agreement between patients' self-report of swelling (mild, moderation and severe) and the extent of circumferential measurement difference between treated side and the contralateral arm at the site of greatest difference. Per protocol, this analysis will include all patients and not be comparing the intervention arm with the control arm.
18 months
Health-related Quality of Life as Assessed by FACT-B +4 Score
Délai: 18 months
To compare the health-related quality of life (FACT-B+4 score) between the two interventions. The change between baseline and month 18 for the total plus 4 score will be reported here. The total plus 4 score is an average of the physical, social, emotional, functional, FACT-G, and additional concerns sub-scales. Each sub-scale has questions ranging from 1-5. Once the average of all subscales is taken, the total plus 4 score is converted into a score out of 100. 100 being the best, 0 being the worst.
18 months
Adherence to Lymphedema Prevention Exercises, Lymphedema Knowledge, Range of Motion, and Arm Strength
Délai: from baseline up to 18 months
To characterize adherence to lymphedema prevention exercises, lymphedema knowledge and range of motion. The frequency of elastic sleeve use for heavy arm use/exercise/air travel will be reported here. Arm I did not receive a sleeve to wear, thus will not be reported.
from baseline up to 18 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: Electra D. Paskett, PhD, Ohio State University Comprehensive Cancer Center

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 juin 2006

Achèvement primaire (Réel)

1 novembre 2015

Achèvement de l'étude (Réel)

15 juin 2017

Dates d'inscription aux études

Première soumission

13 septembre 2006

Première soumission répondant aux critères de contrôle qualité

13 septembre 2006

Première publication (Estimé)

15 septembre 2006

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

27 avril 2026

Dernière vérification

1 avril 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Individual Participant Data Set

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner